These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 20795789)
1. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation. Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789 [TBL] [Abstract][Full Text] [Related]
2. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968 [TBL] [Abstract][Full Text] [Related]
4. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia. Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861 [TBL] [Abstract][Full Text] [Related]
5. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Götze S; Wolter M; Reifenberger G; Müller O; Sievers S Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810 [TBL] [Abstract][Full Text] [Related]
6. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome. Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia. Chim CS; Pang R; Liang R J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431 [TBL] [Abstract][Full Text] [Related]
9. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia. Hou HA; Kuo YY; Liu CY; Lee MC; Tang JL; Chen CY; Chou WC; Huang CF; Lee FY; Liu MC; Yao M; Tien HF Br J Cancer; 2011 Dec; 105(12):1927-33. PubMed ID: 22095226 [TBL] [Abstract][Full Text] [Related]
10. Methylation analysis of SFRP genes family in cervical adenocarcinoma. Lin YW; Chung MT; Lai HC; De Yan M; Shih YL; Chang CC; Yu MH J Cancer Res Clin Oncol; 2009 Dec; 135(12):1665-74. PubMed ID: 19513747 [TBL] [Abstract][Full Text] [Related]
11. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262 [TBL] [Abstract][Full Text] [Related]
12. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Chim CS; Pang R; Fung TK; Choi CL; Liang R Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284 [TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. Takagi H; Sasaki S; Suzuki H; Toyota M; Maruyama R; Nojima M; Yamamoto H; Omata M; Tokino T; Imai K; Shinomura Y J Gastroenterol; 2008; 43(5):378-89. PubMed ID: 18592156 [TBL] [Abstract][Full Text] [Related]
16. Concurrent Evaluation of the Expression and Methylation of Mirzaeyan F; Chahardouli B; Mirzaeian A; Alizad Ghandforoush N; Alimoghaddam K; Rostami S Iran J Med Sci; 2021 May; 46(3):180-188. PubMed ID: 34083850 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells. Masala E; Valencia A; Buchi F; Nosi D; Spinelli E; Gozzini A; Sassolini F; Sanna A; Zecchi S; Bosi A; Santini V Leuk Res; 2012 Oct; 36(10):1290-5. PubMed ID: 22742816 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894 [TBL] [Abstract][Full Text] [Related]
19. DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer. Zhu J; Wang Y; Duan J; Bai H; Wang Z; Wei L; Zhao J; Zhuo M; Wang S; Yang L; An T; Wu M; Wang J J Exp Clin Cancer Res; 2012 Sep; 31(1):80. PubMed ID: 23009178 [TBL] [Abstract][Full Text] [Related]
20. [Application of Bisulfite Sequencing PCR in Detecting the Abnormal Methylation of Suppressor Gene of Wnt Signaling Pathway in Acute Promyelocytic Leukemia]. Yan JG; Fu HY; Shen JZ; Zhou HR; Zhang YY; Huang JL; Chen CJ; Huang SH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1299-1304. PubMed ID: 27784346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]